Pneumomediastinum is a rare clinical finding, but one which can be the source of significant concern for clinicians managing such patients. By presenting these 3 cases, we emphasize that conservative management is usually all that is required, with gradual resorption of the air from the tissues [1]. There have been 2 other COVID-19 patients with pneumomediastinum described in the literature to date, who were also treated conservatively [2–4]. However, it is important to continue to monitor with serial imaging for the development of pneumothorax, which can lead to cardiorespiratory compromise, and also other signs of clinical deterioration. In patients with an accompanying pneumothorax, chest drainage is indicated and if there is ongoing air leakage, this is an indication for thoracic surgery.